A Non-interventional Study of Ability and Willingness to Pay for BIAsp 30 in a Real World Population With Type 2 Diabetes Mellitus (T2DM)
NCT03374774
·
clinicaltrials.gov ↗
COMPLETED
Status
516
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus, Type 2
Interventions
DRUG:
BIAsp 30
Sponsor
Novo Nordisk A/S